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Background: Antimicrobial resistance is a major contemporary public health threat. Strategies to contain antimicrobial
resistance have been comprehensively set forth, however in developing countries where the need for effective
antimicrobials is greatest implementation has proved problematic. A better understanding of patterns and determinants
of antibiotic use and resistance in emerging economies may permit more appropriately targeted interventions.
Viet Nam, with a large population, high burden of infectious disease and relatively unrestricted access to medication, is
an excellent case study of the difficulties faced by emerging economies in controlling antimicrobial resistance.
Methods: Our working group conducted a situation analysis of the current patterns and determinants of antibiotic use
and resistance in Viet Nam. International publications and local reports published between 1-1-1990 and 31-8-2012 were
reviewed. All stakeholders analyzed the findings at a policy workshop and feasible recommendations were suggested to
improve antibiotic use in Viet Nam.
Here we report the results of our situation analysis focusing on: the healthcare system, drug regulation and supply;
antibiotic resistance and infection control; and agricultural antibiotic use.
Results: Market reforms have improved healthcare access in Viet Nam and contributed to better health outcomes.
However, increased accessibility has been accompanied by injudicious antibiotic use in hospitals and the community,
with predictable escalation in bacterial resistance. Prescribing practices are poor and self-medication is common – often
being the most affordable way to access healthcare. Many policies exist to regulate antibiotic use but enforcement is
insufficient or lacking.
Pneumococcal penicillin-resistance rates are the highest in Asia and carbapenem-resistant bacteria (notably NDM-1) have
recently emerged. Hospital acquired infections, predominantly with multi-drug resistant Gram-negative organisms, place
additional strain on limited resources. Widespread agricultural antibiotic use further propagates antimicrobial resistance.
Conclusions: Future legislation regarding antibiotic access must alter incentives for purchasers and providers and ensure
effective enforcement. The Ministry of Health recently initiated a national action plan and approved a multicenter health
improvement project to strengthen national capacity for antimicrobial stewardship in Viet Nam. This analysis provided
important input to these initiatives. Our methodologies and findings may be of use to others across the world tackling
the growing threat of antibiotic resistance.
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Antimicrobial resistance is a global concern and a par-
ticularly pressing issue in resource-limited countries.
Respiratory, diarrheal, sexually-transmitted and nosoco-
mial infections are leading causes of death in the devel-
oping world [1] and their management is critically
compromised by the appearance and rapid spread of
resistance.
Antibiotic drug pressure is a key driver of resistance.
Whilst it is an unavoidable consequence of antibiotic
use – both rational and irrational – unnecessary anti-
biotic pressure can and must be reduced. The World
Health Organization (WHO) published comprehensive
recommendations designed to restrict the emergence
and spread of antimicrobial resistant organisms, pro-
moting prudent use of antimicrobials in humans, food-
producing animals and aquaculture [2].
With a population exceeding 91 million, Viet Nam is
the world’s 13th most populous country (Table 1) and
has a rapidly developing economy [3,4]. In 1986 a
series of economic reforms, termed the Đổi Mới, facili-
tated the transition to a more market-driven economy.
One of the consequences of economic liberalization has
been a relatively unregulated access to antimicrobials
and this, coupled with the high burden of infectious
disease, has made Viet Nam a potential hotspot for the
emergence of drug resistance.
Our paper presents a situation analysis that addresses
the current patterns and determinants of antibiotic use
and resistance in Viet Nam. It suggests how the in-
formation gained during this process can be used to
develop effective interventions to improve antibioticTable 1 Key health and development indicators in Viet Nam
Indicator Year Number
Population (millions) 2013 92.48
Population growth rate (%) 2013 1.03
Urbanization rate (%) 2010-15 3.03
Life expectancy (male/female) 2010-15 77.4/73.4
GDP per capita (PPP) (US$) 2012 3,600
Infant mortality rate (per 1000) 2010-15 18.3
Maternal mortality ratio (per 100,000 live births) 2010 59
Poverty rate (% < 1.25USD/day) 2012 11.3
Access to improved drinking water sources (%) 2010 95
Access to improved sanitation facilities (%) 2010 76
Adult literacy rate (%) 2011 93.4
Sources: World Health Organization (http://apps.who.int/gho/data/view.
country.21300, date accessed: 09/10/2013).
United Nations (http://data.un.org/CountryProfile.aspx?crName=Viet%20Nam,
date accessed: 09/10/2013).
CIA World Factbook (https://www.cia.gov/library/publications/the-world-
factbook/geos/vm.html, date accessed: 09/10/2013).stewardship in Viet Nam, whilst taking care not to di-
minish access to these life-saving drugs.
Formulating policy to improve antibiotic stewardship
is best accomplished by beginning with a broad ana-
lysis of a country and its health system. The first iter-
ation of such an analysis was produced for Viet Nam in
2009, when it became one of the first countries to join
the Global Antibiotic Resistance Partnership [5]. This
paper considers policy recommendations made in light
of that analysis and highlights existing challenges.
Methods
We established a working-group, which included key
representatives from across Viet Nam. The working-group
organized a stakeholder meeting in Hanoi (September,
2009) attended by the Vietnamese Ministry of Health
(MoH), WHO, hospital directors, universities, research
organizations and local and international experts in
public health, agriculture, microbiology, pharmacy,
and clinical infectious diseases. During this and subse-
quent meetings, a framework for the situation analysis
was outlined (Figure 1), with the primary aim of as-
sessing and providing an overview of current patterns
and determinants of antibiotic use and resistance in
Viet Nam.
The analysis focused on bacterial diseases, excluding
HIV, malaria and tuberculosis, and is divided into three
sections: (1) healthcare system, drug regulation and
supply; (2) antibiotic resistance and infection control;
and (3) agricultural antibiotic use. All available sources
in international and local literature since 1990 were
identified, synthesized and discussed at a policy meeting.
We identified sources by searching PubMed for pub-
lished papers from 1-1-1990 to 31-8-2012. The follow-
ing search criteria were used: ‘antibiotic consumption’,
‘antibiotic resistance’, ‘healthcare access’, ‘drug access’,
and ‘Viet Nam’. In addition, we consulted relevant
unpublished reports and local Vietnamese papers and
expertise. Clarification was sought from study investi-
gators for both international and local documents
when methodology or results were unclear. Informa-
tion on existing policy was obtained from the MoH.
Basic health indicators were obtained from the WHO,
United Nations and CIA World Factbook [3,4,6].
The findings were presented at a policy workshop
(June 2011) attended by local stakeholders represent-
ing the same areas of expertise as the initial stake-
holder meeting. All studies were assessed for possible
bias at the policy workshop before stakeholders were
asked to recommend feasible policy changes to control
antibiotic resistance. These recommendations were
presented to the MoH to assist their formulation of a
national action plan to strengthen national capacity for
antimicrobial stewardship in Viet Nam.
Figure 1 An example framework for a situation analysis in an emerging economy like Viet Nam.
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Healthcare system, drug regulation and supply
Healthcare system
Since the 1986 market reforms, several measures have
improved healthcare access in Viet Nam, including
health insurance schemes, enhanced infrastructure and
health facilities and deregulation of drug retail [7].
Approximately 1,000 public hospitals, 100 private hos-
pitals, 35,000 private clinics and 50,000 private phar-
macies and retailers have been established [8]. In 2010
the Vietnamese Ministry of Health estimated that there
were 6.52 physicians and 1.22 pharmacists per 10,000
inhabitants respectively [9].Out-of-pocket health expenditures as a proportion
of total health expenditures are estimated at 61% [10].
Self-medication is cheaper and less time-consuming than
visiting a healthcare provider but often results in in-
appropriate drug use. One study reported average house-
hold expenditure per episode of illness for self-treatment
to be 1 USD, for private providers 1.7 USD, and for pub-
lic providers 4.6 USD [7]. Self-medication avoids lengthy
and costly formal healthcare and is possible because
prescription-only regulations are not enforced [7].
In primary care empiric antimicrobial treatment is the
norm as limited resources make diagnostics difficult
[11]. At present, only larger provincial and national
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antibiotic sensitivity testing. Hospitals commonly choose
to provide profitable diagnostics and infectious disease
diagnostics, needing expensive infrastructure, are often
not profitable [12]. Inadequate laboratory quality control
and assurance, high workloads and staff shortages are
additional challenges, perceived as important drivers for the
frequent and inappropriate antibiotic prescriptions [12].
Drug regulation and supply
Half of all drugs consumed in Viet Nam are made locally
and more than 50% of these are antibiotics [8]. Most
domestic producers are joint-stock companies, in which
the State holds a 46.5% share [5]. This partnership can
complicate drug regulation.
The Pharmaceutical Law (2005) made antibiotics
prescription-only drugs. Despite this, antibiotics con-
tinue to be dispensed without a doctor’s prescription
[13]. In 2007, the circular on Good Pharmacy Practice
(GPP) was issued to improve the standard of pharmacy
[14]. GPP requires pharmacies to have proper facilities,
monitor drug quality, record drug consumption and
comply with the prescription-only regulations. However,
GPP-certified pharmacies continue to dispense antibi-
otics to patient’s who do not possess a doctor’s prescrip-
tion [15]. Currently, there are no sanctions and as of
March 2013 no pharmacy has been penalized for dis-
pensing without prescription.
Several MoH departments issue these drug policies and
are responsible for regulating private and public health-
care facilities. In 2006, 230 full-time health inspectors
were employed to regulate over 39,000 pharmacy outlets
[16]. Given this discrepancy of greater than 150 outlets
per inspector, it is understandable that despite legislation
regulation of the national drug supply chain is weak.
Drug regulation and supply is also problematic at the
local level. The MoH instructs all hospitals to appoint a
Drug and Therapeutics Committee (DTC). The DTC is re-
sponsible for implementing MoH guidelines, establishing
lists of commonly used drugs in their hospitals and advising
on rational antibiotic therapy. Certain “reserved” antibiotics,
should only be dispensed after consultation with the DTC.
A recent MoH instruction requires hospitals to implement
local guidelines for rational and safe drug use, monitor anti-
biotic prescribing, strengthen hospital pharmacies and train
staff to improve knowledge of drug use. However, these re-
quirements are often not met by hospitals.
Patterns of antibiotic use: hospitals
In 2008–09, the most commonly sold antibiotics were
oral 2nd and 3rd generation cephalosporins, followed by
oral broad-spectrum penicillins, macrolides/azalides and
fluoroquinolones. Importantly, relatively new injectable
antibiotics (e.g. cephalosporins, carbapenems) are sold inhospitals, whilst older antibiotics, (e.g. chloramphenicol)
predominate in retail pharmacies.
Antibiotics constitute on average 36% of hospital treat-
ment expenditure [17]. Injectable cephalosporins have
the highest sales value in hospitals and due to their high
price also account for a substantial part of retail phar-
macy sales (IMS Health data for Viet Nam, 2008). As
the risk of resistance to older antibiotics increases it will
become increasingly necessary to use newer and more
expensive antibiotics, resulting in a larger proportion of
hospital budgets being spent on antibiotics.
Particularly concerning is perioperative antibiotic prophy-
laxis [18]. Most surgeons are aware of CDC best practice
guidelines [19] but lack of confidence in laboratory
reporting and infection control policy motivates anti-
biotic overuse. Inappropriate post-operative prophylaxis
has been reported in 91.8% of clean procedures and
96.3% of clean-contaminated procedures, [18] often
employing combination therapy or aminoglycosides,
contrary to CDC guidance. A fear of surgical site infec-
tion (SSI) likely underlies the higher rates of inappropri-
ate prescriptions on surgical wards [20]. Recent studies
show good hand hygiene is effective at reducing SSI rates
[21] and adhering to CDC perioperative prophylaxis
recommendations does not precipitate an increase [22].
The importance of antimicrobial stewardship is not
routinely addressed in medical or pharmacy training
thus knowledge and prescribing habits remain poor. An
ongoing initiative led by the Vietnamese Society of Infec-
tious Diseases aims to raise awareness of the need for
sensible prescribing and improve hospital antibiotic use
(http://vsid.vn/en/about-vinares.html) [23].
Patterns of antibiotic use: community
Mothers usually treat sick children without consulting a
healthcare provider. In 1999, 91% of children in Ba Vi
with symptoms of acute respiratory tract infection (ARI)
were treated with broad-spectrum penicillins, 78% of
them self-medicating. This corresponded to 75% of all
children in that community [24]. From 1999 to 2007
Streptococcus pneumoniae penicillin-resistance rates in-
creased from 8% to 75% in Ba Vi [25]. In 2007, the pat-
tern of antibiotic use changed, as oral cephalosporins
became commonly used for ARI, with similarly high
proportions of patients receiving antibiotics [13].
Reasons for irrational antibiotic prescribing are the
same as in other countries: perceived patient expect-
ation; time constraints; lack of knowledge; lack of diag-
nostics; pressure, incentives and advertising from
industry; and financial benefits for the prescriber [13].
High out-of-pocket costs of formal healthcare mean that
direct purchase of drugs is more affordable for patients.
A major challenge is to identify and modify the incen-
tives for inappropriate prescribing and purchasing.
Figure 2 Resistance rates for four common Gram-negative
bacteria isolated from routine clinical specimens (sputum,
urine, blood, pus) in hospitalized patients [17]. Source: First
report on antibiotic use and resistance in Viet Nam, MoH, 2008–09.
Nguyen et al. BMC Public Health 2013, 13:1158 Page 5 of 10
http://www.biomedcentral.com/1471-2458/13/1158Antibiotic resistance and infection control
Below we summarize data for key bacteria. Most data are de-
rived from site-specific, hospital-based studies, yet the major-
ity of illness occurs where there are few diagnostic facilities.
Gram-positive pathogens
From 1995 to 2000, penicillin-resistance amongst
community-acquired invasive pneumococci increased
from 8% to over 70% (R 71.4%; I 20.6%, n = 64) [26]. Viet
Nam has the highest prevalence of penicillin- (71.4%)
and erythromycin-resistance (92.1%) in Asia [26]. Resist-
ance rates are 22 times higher in urban compared to
rural children [27]. In 2009, most pneumococci were still
susceptible to ceftriaxone [28]. Streptococcus suis is the
leading cause of bacterial meningitis in adults in Viet
Nam. An increase in tetracycline and chloramphenicol
resistance was observed in S. suis over an 11-year period,
associated with agricultural antibiotic use [29].
A recent study on Staphylococcus aureus isolates from blood
showed 19% were methicillin resistant (n = 80) [30]. National
surveillance of community and hospital acquired infections
(HAIs) show methicillin resistance rates up to 40% [17].
Gram-negative pathogens
An enterobacteriaceae study in Ho Chi Minh City re-
ported extended-spectrum beta-lactamase prevalence of
43.8% amongst hospitalized patients (n = 71) with com-
plicated intra-abdominal infections, bloodstream infec-
tions, nosocomial pneumonia and ventilator-associated
pneumonia. Prevalence has been reported to be as high
as 81% amongst ICU enterobacteriaceae [31].
Over 70% of Salmonella Typhi isolated in a southern Viet
Nam study from 1994 were multi-drug resistant (MDR) [32].
Nalidixic acid resistance increased from 4% to 97% in 12 years
[33] Another study confirmed more than 80% of S. Typhi
isolates are resistant to nalidixic acid [34] and this has been
linked to treatment failure [35]. High resistance rates are also
found in stool-isolated Shigella spp. to: trimethoprim-
sulfamethoxazole, 81%; tetracycline, 74%; ciprofloxacin, 10%;
and ceftriaxone, 5% [36]. Over 75% are resistant to more
than one drug [37]. High rates of MDR (resistance to co-
trimoxazole, naladixic acid and tetracycline) are also charac-
teristic of Vibrio cholerae in Viet Nam [38] and prevalence of
commensal MDR (defined as resistance to three or more
antibiotics in this study) Escherichia coli is positively cor-
related with community antibiotic use [39].
Of note are the high resistance rates amongst Helicobac-
ter pylori, the bacteria strongly associated with peptic
ulcer disease. A study in children reported clarithromycin,
metronidazole, and amoxicillin resistance rates of: 50.9%,
65.3%, and 0.5%, respectively. Importantly, clarithromycin
resistance was associated with eradication failure [40].
Gram-negative bacteria producing New Delhi metallo-
beta-lactamase (NDM-1) have been reported from bothnorthern and southern Viet Nam. Furthermore these
bacteria have been found in the Hanoi environment and
reported in a patient admitted to a Ho Chi Minh City
hospital [41,42]. High carbapenem-resistance rates are
found in Pseudomonas aeruginosa and Acinetobacter
baumannii HAIs (Figure 2) [31]. Most are colistin sus-
ceptible, however colistin resistance has been reported
in one northern Viet Nam hospital.
Hospital acquired infections
In one Hanoi hospital, SSIs were associated with in-
creased post-operative stay (8.2 days) and excess direct
costs (110 USD per patient) [43]. HAIs are most com-
mon in ICUs and surgical wards. A study conducted in
ICUs, surgical and obstetric departments of three district
hospitals reported an overall HAI rate of 17.3%: SSIs,
55%; urinary tract infections, 21%; and lower respiratory
tract infections, 17% [44]. Throughout Viet Nam, MDR
Gram-negative bacteria are the most common cause of
HAIs, whereas S. aureus is not.
Infection control
In 2007 most district hospitals had infection control
committees but could do little to tackle issues due to
limited resources. It was noted that guidelines were
often outdated [11]. A recent MoH regulation on infec-
tion control in healthcare institutions, together with up-
dated guidelines and a national health improvement
project [23], represents an effort to improve capacity for
infection control and make health-related activities safer
for patients, staff and visitors.
Effective infection control is difficult as most Vietnam-
ese hospitals are old, overcrowded and workloads are
high. Bed occupancy can exceed 100%, especially during
communicable disease outbreaks. The family is essential
to care: bringing food, feeding and cleaning the patient,
and this is difficult to monitor. Hospital water and solid
waste is often disposed without pretreatment [45].
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and more than 40% of healthcare workers know the ba-
sics of hand hygiene, however lack of facilities are re-
ported to underlie low compliance (13.4%) [46]. Several
hospitals have poor availability of water, soap and wipes.
A recent study in ICUs showed hygiene precautions to
be poor with fewer than 50% of patient contacts incorp-
orating appropriate hand hygiene [47].
Agricultural antibiotic use
Seventy percent of pharmaceuticals used in animals are
antibiotics [48]. Certain antibiotics have been banned
in animals since Viet Nam joined the World Trade
Organization. When residues of banned antibiotics ex-
ceed set limits farms are prohibited from harvesting,
processing and exporting products until the government
confirms compliance. However, regulation is focused on
farms producing for export, not for the domestic market.
Many antibiotics used to treat human disease are used in
agriculture: β-lactams, aminoglycosides, macrolides, tetracy-
clines, (fluoro)quinolones, phenicols, pleuromutilins, linco-
samides, sulfonamides, diaminopyrimidine (trimethoprim)
[48]. Farmers often do not comply with regulations requir-
ing them to stop antibiotic use before harvesting their prod-
ucts [48]. One study reported a positive correlation
between sulfamethoxazole concentration and occurrence of
sulfamethoxazole-resistant bacteria [49]. Alarmingly, poly-
mixins (colistin) are commonly used despite not yet being
registered to treat MDR infections in humans. Recently, it
was found that rifampicin, a key drug for tuberculosis treat-
ment, is being used in agriculture.
In a study performed across 4 continents, prevalence
of MDR Campylobacter in chickens was highest in
Viet Nam [50]. Sixty-six percent of Salmonellae in retail
chicken and pork meat is MDR, with 78.4% of isolates
resistant to at least one antibiotic [51]. An intervention
study showed that fluctuations in bacterial resistance
amongst pigs mirrored addition or withdrawal of antibi-
otics from their feed [52]. Recently, shrimp aquaculture
has expanded and several antibiotics and antibiotic-
resistant bacteria have been detected [53].
Stakeholder recommendations from policy workshop
In June 2011 a policy workshop attended by local stake-
holders representing the same areas of expertise as the
initial stakeholder meeting was convened and the evi-
dence gained from this situation analysis was discussed.
Coordinated and concerted action was recognized as key
to tackling antimicrobial resistance in Viet Nam and
other emerging economies. This action must be carefully
considered to minimize possible adverse health impacts.
A better understanding of appropriate antimicrobial
use must be fostered amongst clinicians. The develop-
ment of a national antibiotic stewardship program iscentral to this. Surveillance programs that specifically
monitor antimicrobial use in hospitals, the community
and agriculture need to be established. Public educa-
tional initiatives should be considered and have potential
for great impact given the high adult literacy rate of
93.4%. It was agreed that adequate legislation already ex-
ists to control antimicrobial resistance in Viet Nam but
there is an urgent need to prioritize effective enforce-
ment and imposition of appropriate penalties (Table 2).
Better mapping of the incentive structure for manufac-
turers, providers and purchasers of antibiotics will likely
improve compliance with existing legislation. The main
priorities from the policy workshop are summarized below.Policy priorities to control antibiotic resistance
1. Enforcement of existing regulations involving
antibiotic use in hospitals, the community and
agriculture with stronger regulatory capacity and
monitoring. The imposition of penalties in a more
effective way should be considered.
2. Develop an antibiotic stewardship program (ASP)
with an ASP steering committee that includes
standard treatment guideline (STG) development,
implementation, regular updates, and audits. STGs
need to be evidence based and use local
epidemiology and resistance rates.
3. Create three national surveillance programs and create
the required national reference laboratories to ensure
the availability and quality of testing for the surveillance
program. The three national surveillance programs are:
• Hospital antibiotic use and resistance (conducted
by MoH)
• Community antibiotic use and resistance (conducted
by NIHE)
• Antibiotic use, resistance and residue in animals
(conducted by MARD).
4. Improve access to non-medicated animal feed for
farmers [54]. It is recommended to limit the use of
colistin in agriculture, as it is a last resort drug for
MDR infections in humans.
5. Improve education regarding antibiotic use and
resistance for those working in the healthcare
system and agriculture.
6. The MoH and MARD are recommended to develop
a joint action plan. During its development,
stakeholders (governmental agencies, WHO, FAO,
hospitals, pharmacies, industry and academia)
should be consulted.
NIHE = National Institute for Hygiene and Epidemiology.
MARD = Ministry of Agriculture and Rural Development.
FAO = Food and Agriculture Organization of the
United Nations.
Table 2 Current policies related to antibiotic use and problems with their implementation
Policy area Problems with implementation Recommendations
Antibiotics are prescription only drugs Discrepancy between number of regulators and retail
outlets. No sanctions or penalties for non-compliance.
Allocate more resources to implement the law. Ensure appropriate sanctions and
penalties are enforced for non-compliant providers. Public educational initiatives
to raise awareness and take advantage of the high literacy rate.
Hospitals need a Drug ad Therapeutics
Committee (DTC)
DTCs are not trained in antimicrobial stewardship
methodologies and do not have access to current
resistance data. Many hospitals do not have DTCs.
Provide tools/guidance on effective hospital antibiotic stewardship. Provide them
with reliable and up-to-date resistance data.
Hospitals need an infection control committee Standardized surveillance structures are not in place.
Many hospitals do not have infection control committees.
Provide infection control committees with funding to carry out their activities and
improve infrastructure. Train them to use standardized surveillance methodologies
and indicators to monitor progress, such as HAI rates by department and hand
washing compliance.
Laboratory enhancement program Inappropriate resistance testing gives erroneous and
discrepant results
Ensure quality of laboratory testing by issuing national testing guidelines, including
quality control strains. Consider setting up a national reference center (center of
excellence) for antibiotic resistance testing and overseeing external quality control.
Create an interactive network for sharing information (data, guidelines, expertise).
National antibiotic resistance surveillance Lack of communication between institutions regarding
resistance data
Pool data from all hospitals to create a national resistance database. Release a
national annual report that includes both antibiotic use and resistance data in
the same document.
Hospital antibiotic use surveillance No standardized reporting of antibiotic consumption data Standardize antibiotic usage indicators to international units, like Defined Daily
Dosage (DDD) per 100 bed days. Release a national annual report that includes
both antibiotic use and resistance data in the same document.
Medical and pharmacy school curriculum Insufficient emphasis placed on antimicrobial stewardship Provide sufficient time to teach and train students on appropriate antibiotic use
and resistance. Highlight the growing public health problem of drug resistance.
Standard treatment guidelines Current treatment guidelines are outdated Ensure timely and evidence based updates of treatment guidelines for infectious
diseases, utilizing local resistance data.
Pharmacovigilance Adequate funding and resources Engage the center for pharmacovigilance in tackling the issue of inappropriate
antibiotic prescribing.
Stop agricultural antibiotic use before
harvesting products
Enforcement focuses on farmers producing for export Enforce the law. Set up a similar national antibiotic use and resistance surveillance
system for the agricultural industry. Compile a national annual report that includes
both antibiotic use and resistance data in the same document.
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a policy workshop in June 2011 which has assisted the
MoH with formulation of a national action plan to im-
prove national capacity for antimicrobial stewardship in
Viet Nam. Many of these priorities may be applicable to




Formulating policy to tackle antimicrobial resistance re-
quires a broad analysis of a country and its health sys-
tem to better understand the patterns and determinants
that drive antibiotic use and resistance. To do this it is
essential to consult local data, however this can be of
poor quality, inadequate or absent. For example whilst
substandard or counterfeit antibiotics (except antimalar-
ials) are not recognized as a particular problem in Viet
Nam, there is insufficient data to draw reliable conclu-
sions with respect to drug quality.
We found that it was necessary to carefully examine the
data and investigate the reliability of the sources before
drawing conclusions upon which we could make credible
policy recommendations. Identifying areas of sub-optimal
data is important as it can motivate improvement. High
quality local data is essential to allow effective interven-
tions to be designed and appropriately targeted.
Mapping of the incentive structure
Effective recommendations to alter antibiotic use must
consider the incentives for manufacturers, providers and
purchasers. Mapping and addressing of the incentive
structures is difficult and requires long-term cooperation
between local stakeholders and policy makers. Regular
review of any intervention is necessary to assess whether
it has been successful in modifying these incentives and
changing behavior.
Conclusions
Increased access to antibiotics has contributed to improved
health outcomes in Viet Nam. However antibiotic overuse
in hospitals, the community and agriculture has promoted
rapid development of bacterial resistance, eroding the
health asset antimicrobials constitute. As a result Viet Nam,
like many emerging economies, faces a considerable chal-
lenge in attempting to control antimicrobial resistance.
Antimicrobial resistance may represent the greatest
global threat by an Emerging Infectious Disease issue. Its
insidious nature may not have the cache of SARS, pan-
demic influenza or Ebola but its impact on public health
is likely to be far greater. Like other Emerging Infectious
Diseases, drug resistance can quickly spread from one
country to another and hence the need for concerted na-
tional and international action.There is consensus amongst the political and medical
leadership of Viet Nam that antibiotic resistance is a
serious and growing problem. The emergence and
spread of carbapenem-resistant Gram-negative bac-
teria, a phenomenon not unique to Viet Nam, illus-
trates this. High resistance rates mean that many
antibiotic regimens in current treatment guidelines are
already ineffective across a broad range of clinical syn-
dromes and pathogens. There are many examples of le-
gislation and initiatives designed to limit unnecessary
antibiotic use (Table 2). However, judged against their
intended goal, these policies have been ineffective.
High individual out-of-pocket expenditure may have in-
creased consumer control and weakened the influence of
the State on the healthcare market. Policies to reduce out-
of pocket expenditure through health insurance may re-
duce the ability of individuals to shape the healthcare mar-
ket and be important in revitalizing the influence of the
State [55]. Point-of-care tests to improve diagnostics in
primary healthcare may reduce antibiotic overuse. These
and other policy options need careful consideration for
their feasibility, affordability and possible adverse impacts.
There are many barriers preventing effective enforce-
ment of regulations designed to improve antimicrobial
stewardship in developing countries: insufficient funding
and lack of expertise, human resources and financial in-
centives. It is important to foresee possible negative conse-
quences of enforcement: financial losses and reduced
healthcare access. Accounting for this will improve policy
implementation in these settings. Furthermore, it is im-
portant to know where to focus regulatory efforts: a focal
point too far downstream may create targets too numer-
ous or dispersed for enforcement to be feasible.
Patients, physicians, veterinarians, clinics and hospi-
tals, and retailers – from large pharmacies to local drug
sellers – have little motivation to weigh the negative im-
pact of their antibiotic use on others, especially those in
the future. Policy solutions must alter incentives for pa-
tients, physicians and others in the healthcare system to
act in society’s best interests. Better quantification and
mapping of the incentive structure for antibiotic pre-
scribing in emerging economies would support the de-
sign of more effective interventions.
Antibiotic resistance does not yet top any list of national
healthcare problems for Viet Nam or other emerging econ-
omies. Antibiotic stewardship should not drain resources
from more pressing concerns. Done correctly, controlling
antibiotic resistance should either be cost neutral or one of
the few health interventions that saves money.
Recently the MoH in Viet Nam has approved a na-
tional action plan to control antibiotic resistance, which
includes development of systematic surveillance struc-
tures to monitor antibiotic use and resistance, and
laboratory participation in quality assurance schemes.
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available to implement this national action plan. Part of
this analysis has provided important input to this initiative,
illustrating that with relatively little effort and funds, a lot
can be achieved on a national scale. We believe it can be a
useful framework for similar initiatives in other countries,
and emerging economies in particular.Competing interests
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